Meta-analysis reveals evolving patterns of antimicrobial resistance in healthcare-associated infections, highlighting risks in low-income countries.
Over six decades, global surveillance has revealed major shifts in healthcare-associated infections and antimicrobial resistance. Synthesizing data from multicontinental studies spanning 1992-2021, early reports showed balanced Gram-positive and Gram-negative pathogens with rising methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE). Subsequent findings indicated a shift toward multidrug-resistant Enterobacterales, persistent ICU non-fermenters, and emerging Candida auris, alongside declining MRSA and Clostridioides difficile rates but increasing carbapenem resistance in Klebsiella pneumoniae and Acinetobacter baumannii. Low- and middle-income countries reported higher infection rates and greater Gram-negative burdens. Overall, infections have transitioned from staphylococcal dominance to multidrug-resistant Gram-negative pathogens and fungi, highlighting the need for locally tailored infection control, rapid diagnostics, and stewardship strategies.
No takes yet. Share an insight, caveat, or question.
Khristi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: